MidWestOne Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

MidWestOne Financial Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,340	Closed	-$205K	–	246
2021 Q4	$205K	Hold	1,340	–	–	0.04%	237
2021 Q3	$217K	Hold	1,340	–	–	0.05%	221
2021 Q2	$219K	Hold	1,340	–	–	0.05%	216
2021 Q1	$202K	Hold	1,340	–	–	0.05%	210
2020 Q4	$203K	Buy	+1,340	New	+$192K	0.06%	202

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MidWestOne Financial Group's IBB Position: Q1 2022 in Review

MidWestOne Financial Group sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,340 shares — an estimated $205K sold.

MidWestOne Financial Group first reported a position in IBB in Q4 2020 and held it in 5 quarters. The position peaked at $219K in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

MidWestOne Financial Group reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
MidWestOne Financial Group sold 1,340 iShares Biotechnology ETF shares in Q1 2022, an estimated $205K.
MidWestOne Financial Group first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 5 quarters.
MidWestOne Financial Group's iShares Biotechnology ETF position peaked at $219K in Q2 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on MidWestOne Financial Group's 13F filing for Q1 2022, filed 17 May 2022.